Angela María Martínez Valverde-rekin lankidetzan egindako argitalpenak (18)

2020

  1. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-18

2019

  1. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 7

2018

  1. IGF-1, inflammation and retinal degeneration: A close network

    Frontiers in Aging Neuroscience, Vol. 10, Núm. JUL

  2. Imbalance between pro-apoptotic and pro-survival factors in human retinal pericytes in diabetic-like conditions

    Acta Ophthalmologica, Vol. 96, Núm. 1, pp. e19-e26

  3. The sp2-iminosugar glycolipid 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin (DSO2-ONJ) as selective anti-inflammatory agent by modulation of hemeoxygenase-1 in Bv.2 microglial cells and retinal explants

    Food and Chemical Toxicology, Vol. 111, pp. 454-466

2017

  1. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

    Hepatology, Vol. 65, Núm. 3, pp. 950-968

  2. Modulation of microglia in the retina: new insights into diabetic retinopathy

    Acta Diabetologica, Vol. 54, Núm. 6, pp. 527-533

  3. Somatostatin protects human retinal pericytes from inflammation mediated by microglia

    Experimental Eye Research, Vol. 164, pp. 46-54

  4. Targeting inflammation in the retina: A new therapeutic approach in diabetic retinopathy

    Anales de la Real Academia Nacional de Farmacia, Vol. 83, Núm. 1, pp. 81-92

2016

  1. Autophagy resolves early retinal inflammation in Igf1-deficient mice

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 9, pp. 965-974

  2. Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy

    Acta Diabetologica, Vol. 53, Núm. 6, pp. 957-964

  3. Friedelane-type triterpenoids as selective anti-inflammatory agents by regulation of differential signaling pathways in LPS-stimulated macrophages

    Toxicology and Applied Pharmacology, Vol. 313, pp. 57-67

  4. Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1663-1674

  5. Rapamycin negatively impacts insulin signaling, glucose uptake and uncoupling protein-1 in brown adipocytes

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1861, Núm. 12, pp. 1929-1941

  6. Somatostatin protects photoreceptor cells against high glucose–induced apoptosis

    Molecular Vision, Vol. 22, pp. 1522-1531

  7. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes

    Diabetes, Vol. 65, Núm. 1, pp. 172-187

2015

  1. Inhibition of protein tyrosine phosphatase 1B improves IGF-I receptor signaling and protects against inflammation-induced gliosis in the retina

    Investigative Ophthalmology and Visual Science, Vol. 56, Núm. 13, pp. 8031-8044

2013

  1. Loss of protein tyrosine phosphatase 1B increases IGF-I receptor tyrosine phosphorylation but does not rescue retinal defects in IRS2-deficient mice

    Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 6, pp. 4215-4224